View : 4 Download: 0
Differentiation of human tonsil-derived mesenchymal stem cells into Schwann-like cells improves neuromuscular function in a mouse model of Charcot-Marie-Tooth disease type 1A
- Differentiation of human tonsil-derived mesenchymal stem cells into Schwann-like cells improves neuromuscular function in a mouse model of Charcot-Marie-Tooth disease type 1A
- Park S.; Jung N.; Myung S.; Choi Y.; Chung K.W.; Choi B.-O.; Jung S.-C.
- Ewha Authors
- SCOPUS Author ID
- Issue Date
- Journal Title
- International Journal of Molecular Sciences
- vol. 19, no. 8
- Charcot-Marie-Tooth disease type 1a; Neuromuscular regeneration; Remyelination; Schwann cells; Tonsil-derived mesenchymal stem cells
- MDPI AG
- Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited motor and sensory neuropathy, and is caused by duplication of PMP22, alterations of which are a characteristic feature of demyelination. The clinical phenotype of CMT1A is determined by the degree of axonal loss, and patients suffer from progressive muscle weakness and impaired sensation. Therefore, we investigated the potential of Schwann-like cells differentiated from human tonsil-derived stem cells (T-MSCs) for use in neuromuscular regeneration in trembler-J (Tr-J) mice, a model of CMT1A. After differentiation, we confirmed the increased expression of Schwann cell (SC) markers, including glial fibrillary acidic protein (GFAP), nerve growth factor receptor (NGFR), S100 calcium-binding protein B (S100B), glial cell-derived neurotrophic factor (GDNF), and brain-derived neurotrophic factor (BDNF), which suggests the differentiation of T-MSCs into SCs (T-MSC-SCs). To test their functional efficiency, the T-MSC-SCs were transplanted into the caudal thigh muscle of Tr-J mice. Recipients’ improved locomotive activity on a rotarod test, and their sciatic function index, which suggests that transplanted T-MSC-SCs ameliorated demyelination and atrophy of nerve and muscle in Tr-J mice. Histological and molecular analyses showed the possibility of in situ remyelination by T-MSC-SCs transplantation. These findings demonstrate that the transplantation of heterologous T-MSC-SCs induced neuromuscular regeneration in mice and suggest they could be useful for the therapeutic treatment of patients with CMT1A disease. © 2018 by the authors. Licensee MDPI, Basel, Switzerland.
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.